CoChat

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

Open access
Biederman, Joseph, Spencer, Thomas, Wilens, Timothy · 2004 · The International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index; none of the 150 sources its claims cite is checked for support yet.

Abstract

There is a substantial body of literature documenting the efficacy of multiple unrelated pharmacological agents in attention-deficit hyperactivity disorder (ADHD) individuals throughout the life-cycle. The available literature indicates the important role of psychopharmacological agents in the reduction of the core symptoms of ADHD and associated impairments. The literature documents that stimulants not only improve abnormal behaviours of ADHD, but also improves self-esteem, cognition, and social and family function. However, response varied in different age groups and with certain comorbidities. In addition there is a large body of literature documenting the efficacy of atomoxetine which shows improvement in these same domains. More research is needed on alternative pharmacological treatments and to further evaluate established therapeutics beyond school-aged Caucasian boys. Further, more research is needed on the efficacy of treatment for comorbid ADHD, use of combined medications, and the combination of medication and psychosocial treatment.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1461145703003973

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 11 Not valid · 113 Not checked · 48 Own results and interpretations

80 more claims

Create a free account to see all 172 claims and to verify the 150 references still open.

See all claims — free account
  • It may state two separate claims as one. 75
  • Probably not a substantial claim. 25
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 140 references

Research works printed but not linked: 13

  1. Arnold L (2000). Methylphenidate vs. amphetamine: comparative review. Journal of Attention Disorders 3, 200-211.
  2. Bergman A, Winters L, Cornblatt B (1991). Methylphenidate: effects on sustained attention. In: Greenhill L, Osman B (Eds.), Ritalin: Theory and Patient Management (pp. 223-231). New York : Mary Ann Liebert Inc.
  3. Biederman J, Milberger S, Faraone S, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E (1994). Family environmental risk factors for attention deficit hyper- activity disorder: a test of Rutter's indicators of adversity. Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry.
  4. Findling R, Schwartz M, Flannery D, Manos M (1996). Venlafaxine in adults with ADHD: an open trial. Journal of Clinical Psychiatry 57, 184-189.
  5. Gittleman R (1980). Childhood Disorders. In : Klein D, Quitkin F, Rifkin A, Gittleman R (Eds.), Drug Treatment of Adult and Child Psychiatric Disorders (pp. 576-756).
  6. Gittleman-Klein R (1974). Pilot clinical trial of imipramine in hyperkinetic children. In: Conners CK (Ed.), Clinical Use of Stimulant Drugs in Children (pp. 192-201). The Hague, Netherlands: Excerpta Medica.
  7. Gittleman-Klein R (1987). Pharmacotherapy of childhood hyperactivity: an update. In : Meltzer HY (Eds.), Psycho- pharmacology : The Third Generation of Progress (pp. 1215-1224). New York : Raven Press.
  8. Pomerleau O, Downey K, Stelson F, Pomerleau C (1995). Cigarette smoking in adult patients diagnosed with ADHD. Journal of Substance Abuse 7, 373-378.
  9. Prince J, Wilens T, Biederman J, Spencer T, Wozniak J (1996). Clonidine for ADHD related sleep disturbances: a systematic chart review of 62 cases. Journal of the American Academy of Child and Adolescent Psychiatry 35, 599-605.
  10. Spencer T, Biederman J, Kerman K, Steingard R, Wilens T (1993a). Desipramine in the treatment of children with Tic disorder or Tourette's Syndrome and attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 32, 354-360.
  11. Spencer T, Biederman J, Wilens T (1997). Pharmacotherapy of ADHD: a life span perspective. In: Oldham J, Riba M (Eds.), American Psychiatric Press Review of Psychiatry (pp. 87-128). Washington, DC : American Psychiatric Association.
  12. Swanson J, Agler D, Fineberg E, Wigal S, Flynn D, Fineberg K, Quintana Y, Talebi H (2000). University of California, Irvine, laboratory school protocol for pharmacokinetic and pharmacodynamic studies. In : Greenhill L, Osman BB (Eds.), Ritalin: Theory and Practice, 2nd edn (pp. 405-430).
  13. Zametkin AJ, Rapoport JL (1987). Noradrenergic hypothesis of attention deficit disorder with hyperactivity : a critical review. In : Meltzer HY (Ed.), Psychopharmacology : The Third Generation of Progress (pp. 837-842). New York: Raven Press.

Cited by

See all 257

Metadata

Authors
Biederman, J., Spencer, T., & Wilens, T.
Affiliations
Massachusetts General Hospital (US)
Corresponding author
Biederman, Joseph
Venue
The International Journal of Neuropsychopharmacology
Published
2004-03
Volume
7
Issue
1
Pages
77-97
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2058706567
Cited by
253
References
140
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 3 · 2020: 59 · 2019: 5 · 2018: 7 · 2017: 3 · 2016: 8 · 2015: 9 · 2014: 9 · 2013: 15 · 2012: 12
FWCI
2.32
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts General Hospital
  • National Institutes of Health
  • National Institute of Mental Health (R01MH050657, 5R29MH575105, 5R01MH50657-10)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD036317, 5R01HD36317-05)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
Keywords
attention deficit hyperactivity disorder, ADHD medication, stimulant medication, atomoxetine, ADHD comorbidity, self-esteem, cognitive function, age differences in treatment response
MeSH terms
Atomoxetine Hydrochloride, Adrenergic alpha-Agonists, Adult, Central Nervous System Stimulants, Antidepressive Agents, Attention Deficit Disorder with Hyperactivity, Child, Clonidine, Delayed-Action Preparations, Humans, Methylphenidate, Propylamines, Guanfacine, Bupropion, Antidepressive Agents, Second-Generation, Adrenergic Uptake Inhibitors, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. https://app.cochat.ai/papers/10.1017/s1461145703003973
The paper
Biederman, J., Spencer, T., & Wilens, T. (2004). Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145703003973

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.